Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Arthritis
Sort By
Newest First
1 / 1
1 / 1
CBD
Regen BioPharma Successfully Treats Rheumatoid Arthritis Using Cannabidiol (CBD) Based Immune Modulatory Treatments
Regen BioPharma Inc.
PR-M10-19-NI-009
Oct 07, 2019
Positive Results
Lilly Presents Positive Results for Taltz® vs. Humira®in Patients with Active Psoriatic Arthritis
Eli Lilly and Company
PR-M06-19-NI-023
Jun 18, 2019
Drug Development
Novartis Cosentyx® First to Show Efficacy in All Key Manifestations of Psoriatic Arthritis
Novartis
PR-M06-19-NI-020
Jun 17, 2019
FDA Approval
UCB Given FDA Okay for Anti-Arthritis Drug
Emilie Branch
Pharma's Almanac
PAO-M04-19-NI-008
Apr 02, 2019
FDA Approval
FDA Approves Treatment for Patients with a Type of Inflammatory Arthritis
U.S. Food & Drug Administration
PR-M04-19-NI-001
Apr 01, 2019
Postmarketing Trial
FDA Responds to Safety Signal Reported in Required Postmarketing Trial for Xeljanz
U.S. Food & Drug Administration
PR-M02-19-NI-068
Feb 28, 2019
FDA Approval
Fresh RA Treatment from Sanofi/Regeneron Approved
Emilie Branch
Pharma's Almanac
PAO-M05-17-NI-024
May 23, 2017
